You searched for "field"

1194 results found

Ciliatech appoints world-class panel of eyecare specialists to newly created KOL advisory board

Ciliatech will leverage ophthalmic expertise of seven-member advisory board to bring to market Intercil® Uveal Spacer, a novel glaucoma implant offering unique benefits to eye surgeons and patients across the globe Ciliatech, an innovative medtech company focusing on the treatment...

Getting the Duke Elder examination right: reflections and tips from a medical student

The Duke Elder undergraduate prize examination is an annual exam organised by the Royal College of Ophthalmologists in the United Kingdom. Named after Sir Stewart Duke Elder, a prominent British ophthalmologist, the exam is designed to encourage undergraduate medical students...

Transferring imaging from primary to secondary care (part 1)

Transferring clinical imaging from high street optometrists to secondary care is an increasingly requested option, especially in the context of the COVID-19 pandemic. A wide variety of solutions exist to allow this, each with their own merits and shortcomings. For...

Primary visual pathway changes in individuals with chronic mild traumatic brain injury

Patients with mild traumatic brain injury (mTBI) often self-report vision disturbance despite showing no reduction of visual acuity or fundus examination abnormality. This prospective, observational, cross-sectional study aimed to determine if using a sweeping array of investigations can help diagnose...

FAQs about cerebral visual impairment (CVI): identifying and helping those affected

Cerebral visual impairment is common in both adults and children, yet the diagnosis can easily be missed unless one is tuned into the presenting features. This article provides a succinct introduction to this important topic. What is vision? Vision is...

An interview with a glaucoma consultant: Insights for aspiring trainees

In this article, Resident Doctor Chi Kit Yan sits down with Consultant Glaucoma Specialist Salman Sadiq and explores the daily life of a glaucoma specialist, the pros and cons of the role, how trainees can prepare for this subspecialty, and...

Refined glaucoma referral practice offers prospect of improved capacity and expanded role for primary eye care professionals

Glaucoma is the most frequent cause of irreversible blindness worldwide and the second leading cause of blindness in the UK [1,2]. The global prevalence of glaucoma in 2010 was approximately 3.5% for people aged 40-80 years, according to Jonas et...

Christoph Schoess awarded prestigious Theodor Leber Medal by the DOG

At the opening ceremony at their annual congress (10–13 October) in Berlin, Germany, the German Ophthalmological Society (DOG) awarded Christoph Schoess, founder and long-serving Managing Director of Heidelberg Engineering, the esteemed Theodor Leber Medal. This prestigious accolade is presented to...

PREVIEW: UKISCRS Cornea & Cataract Day

Taking place on Monday 19 May at The Hilton Liverpool (L1 8LW), just a stone's throw away from 2025's RCOphth Annual Congress, you will be able to find the wonderful team from UKISCRS hosting their Cornea & Cataract Day. Our...

Conference Report: KCL Ophthalmology Society Annual Conference 2025

King’s College London (KCL) Ophthalmology Society 2024/25 hosted the third Annual KCL Ophthalmology National Conference 2025, entitled ‘Advancements and the Future of Ophthalmology’ in London on 5 April 2025. Held at Guy’s Campus, the event drew a wide audience from...

Dec/Jan 2016 Quiz

History A 40-year-old swimming instructor undergoes an enucleation for a blind painful eye. There is a history of soft contact lens wear. She has had a corneal abscess and corneal graft procedures in the past. Questions 1. What does this...

RaScaL Study

The RaScaL study was a six month, single-centre, controlled, prospective phase I/II study in which subjects with diabetic macular oedema (DME) and associated peripheral nonperfusion on ultrawide-field fluorescein angiography (UWFA) were randomised to: (1) study arm: ranibizumab (0.5 mg) injection...